EAEzzat AbuAzzah

Ezzat AbuAzzah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ezzat AbuAzzah has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bridging TG‐116 and TG‐232: A retrospective multi‐vendor evaluation of deviation index re‐centering and process control in digital radiography

    by Ezzat AbuAzzah, Faisal Alrehily, Moawia Gameraddin, Sultan Alshoabi, Walaa Alsharif, Kamal Dahan Alsultan, Abdullah Alshamrani, Khaled Al‐Radadi, Ramy Badawy, Samer Al‐Jabri, et al.

    Background: The deviation index (DI) is a vendor‐neutral indicator of detector exposure relative to the configured target exposure index (TEI). Because TEI is a protocol value rather than a calibrated physical quantity, poorly aligned TEI settings can create systematic DI offsets, obscure protocol problems, and prevent meaningful statistical process control. Objective: This retrospective multi‐vendor study evaluated whether routine DICOM metadata can identify biased DI distributions, separate fixed TEI‐setting offsets from protocol‐adherence variation, estimate candidate TEI updates, and support TG‐232‐aligned standard deviation‐based monitoring after DI re‐centering. Methods: We retrospectively analyzed 38 916 digital radiography examinations performed from January 1, 2024 through August 27, 2024 using three vendor platforms at a tertiary hospital. DICOM metadata were benchmarked against published technical standards using a composite adherence index (CAI) for SID, kVp, mAs, grid use, and AEC use. A secondary gradient‐boosting/SHAP analysis was retained as a non‐causal variance discovery to rank the metadata patterns used to predict DI. Candidate TEI updates were estimated within the vendor‐region‐projection groups by algebraically re‐centering the observed mean DI ( to 0.0. Robustness was assessed using sensitivity analyses restricted by automatic exposure control, beam energy, and patient habitus proxy measures. Results: The baseline = −3.1 (SD 3.7), and only 11.3% of examinations were within |DI| ≤ 1. Forty of 45 vendor–region–projection groups (88.9%) had an absolute group greater than 1.0. Separately, the mean CAI was 0.176. The secondary SHAP analysis ranked the configured TEI, manufacturer, SID, exposure, and kVp as high‐contribution predictors of DI; these findings were interpreted as predictive attribution, not causal evidence. DI re‐centering reduced the overall variance by 42.9% (13.5 to 7.7), increased the proportion of examinations within |DI| ≤ 1 to 34.3%, and reduced severe deviations (|DI| > 3) from 60.3% to 23.1%. Conclusion: In this retrospective, multi‐vendor study, the TEI setting review was operationalized as a structured, data‐driven responsibility of a clinical site. By verifying protocol adherence, equipment performance, image quality, and dose indicators before centering the , departments can support the conversion of the DI from a biased compliance signal into a practical process‐control metric for exposure governance.

  • Open Access

    Tumor-Intrinsic DNA Damage Signaling Is Associated with MHC-I Expression and CD8 Cytotoxic T-Cell Engagement in Triple-Negative Breast Cancer

    by Zinab O. Doha, Ezzat AbuAzzah, Hakeemah H. Al-Nakhle

    Triple-negative breast cancer (TNBC) is characterized by marked immune microenvironment heterogeneity and variable chemotherapy response, yet the epithelial transcriptional programs governing cytotoxic immune activation remain poorly understood. We performed an exploratory, integrative analysis using single-cell RNA sequencing of 31,962 cells from eight TNBC patients operationally stratified into Good and Bad Prognosis groups based on pathological lymphoid infiltration, a discovery grouping subsequently validated against pathological complete response (pCR) in three independent bulk RNA-seq cohorts. This analysis identified four epithelial transcriptional states. The G5 DNA damage subpopulation—predominantly restricted to Good Prognosis tumors (29.2% vs. 0%)—and the G4 Metabolism subpopulation—2.4-fold enriched in Bad Prognosis—were the primary prognostic signatures. Machine learning validation using nested leave-one-cohort-out (LOCO) cross-validation across 614 samples demonstrated that G4 + G5 raw genes with random forest yielded the largest observed mean AUC of 0.653, though these results are exploratory and do not establish a validated clinical classifier. CellChat ligand–receptor interaction analysis revealed that G5 DNA-damage epithelial cells are the dominant immune activators in Good Prognosis TNBC, predominantly engaging CD8 cytotoxic T cells through MHC-I antigen presentation via HLA-A/B/C/E/F → CD8A/CD8B interactions, the highest-probability signaling pathway identified. Spatial transcriptomics independently validated significantly higher DNA damage and CD8 T-cell scores in Good Prognosis tissue. Together, these exploratory findings suggest a framework in which tumor-intrinsic DNA damage signaling is associated with MHC-I antigen presentation upregulation and CD8 cytotoxic T-cell engagement, supporting further investigation of this axis and its potential implications for combining DNA-damaging chemotherapy with immune checkpoint blockade in TNBC.

  • Open Access

    Schistosoma Mansoni and Haematobium: Radiological Diagnostic Clues and Pathophysiology

    by Sultan Abdulwadoud Alshoabi, Abdullatif O. Magram, Abdulaziz H. Alkalady, Rafat Rashed Al-Maqtari, Khaled M. Almas, Khaled Mohammed Al-Sayaghi, Abdullgabbar M. Hamid, Fahad H. Alhazmi, Abdulaziz A. Qurashi, Walaa Alsharif, et al.

    Schistosomiasis (bilharzia) is a parasitic infection caused by trematodes of the Schistosoma genus and remains a significant health burden in endemic regions. Granulomatous host responses to deposited Schistosoma eggs in small veins and tissues result in progressive changes and characteristic imaging findings. This diagnostic radiological review synthesizes the published literature and highlights key and robust imaging findings that facilitate the diagnosis of Schistosoma mansoni and Schistosoma haematobium, with emphasis on modality-specific patterns and disease staging. Schistosoma mansoni primarily affects the liver, causing periportal fibrosis visible as “pipe-stem” echogenic thickening upon ultrasonography, which may progress to portal hypertension and chronic liver disease. Liver cirrhosis is the end-stage disease manifested as an irregular liver contour with surface nodularity and lobar redistribution as right lobe atrophy with left and/or caudate lobe hypertrophy. Schistosoma haematobium predominantly affects the genitourinary system, causing urinary bladder wall thickening and calcification. Early disease, within three months of infection, may present with fine calcification, firstly in the bladder base and then extending to the whole bladder and even to the ureters. Calcification appears as a line or two parallel lines on radiography and as a circle in axial computed tomography (CT) images, which is pathognomonic for early-stage Schistosomiasis. In contrast studies, including conventional urography and CT urography, Schistosoma eggs appear as bubble-like filling defects in the ureter, kidney, and bladder, manifested as ureteritis, pyelitis, and cystitis cystica. Late stages appear as coarse calcification, fibrosis, strictures, and reduced bladder capacity and are associated with an increased risk of bladder squamous cell carcinoma. Moreover, Schistosomiasis calcification can present in genital organs, especially in the seminal vesicles; in the prostate in males; and in the vulva, cervix, and perineum in females. Ultimately, Schistosoma mansoni and haematobium eggs can reach the spinal cord, leading to acute myelopathy with paraparesis, urinary retention, or paraplegia. Recognition of characteristic imaging patterns of Schistosomiasis is essential for early diagnosis, accurate staging, and prevention of long-term complications.